3 results
Primary Objective: Does induced hypothermia using NovathermTM combined with the iLA-Activve MinilungTm result in a reduction in minute volume ventilation and work of breathing by reducing positive peak inspiratory pressure levels in patients with…
Part 1:To evaluate the effects of 52 weeks of treatment with basmisanil on core symptom domains of Dup15q syndrome (language and social skills) and dailyfunctioning. Part 2:• To evaluate the tolerability and safety of up to 3 years of treatment with…
The primary objective of the study is survival on a Carmat device at 180 days post-implant* or survival to cardiac transplantation if occurring before 180 days post-implant**. * The beginning of the implant procedure is defined as the start of the…